Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-20,963
Closed -$582K 440
2024
Q1
$582K Buy
20,963
+13,914
+197% +$386K 0.05% 212
2023
Q4
$203K Sell
7,049
-16,331
-70% -$494K 0.02% 292
2023
Q3
$776K Sell
23,380
-458
-2% -$16.2K 0.07% 136
2023
Q2
$874K Sell
23,838
-3,591
-13% -$140K 0.08% 118
2023
Q1
$1.12M Buy
27,429
+11,496
+72% +$497K 0.1% 107
2022
Q4
$816K Buy
15,933
+1,647
+12% +$79K 0.08% 118
2022
Q3
$625K Sell
14,286
-6,077
-30% -$295K 0.07% 121
2022
Q2
$1.07M Sell
20,363
-244
-1% -$12.4K 0.11% 86
2022
Q1
$1.07M Buy
20,607
+3,586
+21% +$186K 0.09% 95
2021
Q4
$1M Sell
17,021
-2,157
-11% -$107K 0.09% 71
2021
Q3
$825K Buy
+19,178
New +$850K 0.09% 76
2021
Q2
Sell
-10,913
Closed -$395K 246
2021
Q1
$395K Sell
10,913
-5,007
-31% -$178K 0.05% 119
2020
Q4
$586K Sell
15,920
-3,551
-18% -$130K 0.08% 85
2020
Q3
$678K Buy
19,471
+3,356
+21% +$118K 0.1% 69
2020
Q2
$500K Buy
+16,115
New +$547K 0.08% 81
2019
Q3
Sell
-5,992
Closed -$246K 136
2019
Q2
$246K Buy
+5,992
New +$238K 0.04% 116

Other funds holding PFE

Trek Financial's PFE Position: Q2 2024 in Review

Trek Financial sold out of Pfizer (PFE) in Q2 2024, closing a stake of 20,963 shares — an estimated $582K sold.

Trek Financial first reported a position in PFE in Q2 2019 and held it in 16 quarters. The position peaked at $1.12M in Q1 2023. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Trek Financial reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Trek Financial sold 20,963 Pfizer shares in Q2 2024, an estimated $582K.
  • Trek Financial first reported a position in Pfizer in Q2 2019 and held it in 16 quarters.
  • Trek Financial's Pfizer position peaked at $1.12M in Q1 2023.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Trek Financial's 13F filing for Q2 2024, filed 12 Aug 2024.